Impact of cyclosporine-based immunosuppressive therapy on liver histology of hepatitis C virus-infected renal transplant patients

Hepatology

Volumn 48, Issue 1, 2008, Pages 348-349

  Schiavon, Leonardo L ^a   Carvalho Filho, Roberto J ^a   Narciso Schiavon, Janaína L ^a   Barbosa, Denize V ^a   Lanzoni, Valéria P ^a   Ferraz, Maria Lucia G ^a   Silva, Antonio Eduardo B ^a  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; CYCLOSPORIN A; IMMUNOSUPPRESSIVE AGENT; VIRUS RNA;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANTIVIRAL ACTIVITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; FEMALE; GRAFT RECIPIENT; HEPATITIS C; HUMAN; IMMUNOMODULATION; IMMUNOSUPPRESSIVE TREATMENT; INFECTION RISK; INFLAMMATION; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; LETTER; LIVER BIOPSY; LIVER FIBROSIS; LIVER HISTOLOGY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; VIREMIA; VIRUS TITRATION;

CYCLOSPORINE; HEPATITIS C, CHRONIC; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LIVER; LIVER TRANSPLANTATION;

EID: 47149111399     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1002/hep.22331     Document Type: Letter

References (8)

1. Pawlotsky JM, Chevaliez S, McHutchison JG. The hepatitis C virus life cycle as a target for new antiviral therapies. Gastroenterology 2007;132:1979-1998.
2. Fernandes F, Poole DS, Hoover S, Middleton R, Andrei AC, Gerstner J, et al. Sensitivity of hepatitis C virus to cyclosporine A depends on non-structural proteins NS5A and NS5B. HEPATOLOGY 2007;46:1026-1033.
3. Nakagawa M, Sakamoto N, Tanabe Y, Koyama T, Itsui Y, Takeda Y, et al. Suppression of hepatitis C virus replication by cyclosporin a is mediated by blockade of cyclophilins. Gastroenterology 2005;129:1031-1041.
4. Watashi K, Hijikata M, Hosaka M, Yamaji M, Shimotohno K. Cyclosporin A suppresses replication of hepatitis C virus genome in cultured hepatocytes. HEPATOLOGY 2003;38:1282-1288.
5. Villamil F, Levy G, Grazi GL, Mies S, Samuel D, Sanjuan F, et al. Long-term outcomes in liver transplant patients with hepatic C infection receiving tacrolimus or cyclosporine. Transplant Proc 2006;38:2964-2967.
6. Rayhill SC, Barbeito R, Katz D, Voigt M, Labrecque D, Kirby P, et al. A cyclosporine-based immunosuppressive regimen may be better than tacrolimus for long-term liver allograft survival in recipients transplanted for hepatitis C. Transplant Proc 2006;38:3625-3628.
7. Fabrizi F, Martin P, Ponticelli C. Hepatitis C virus infection and renal transplantation. Am J Kidney Dis 2001;38:919-934.
8. Perez RM, Ferreira AS, Silva IS, Medina-Pestana JO, Lanzoni VP, Silva AE, et al. Hepatitis C virus infection in renal transplant patients: a comparative study with immunocompetent patients. Clin Transplant 2005;19:763-768.